The US Food and Drug Administration (FDA) has granted fast track designation to Sumitomo Pharma America’s (SMPA) DSP-5336 for ...

AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.

AusperBio has raised $37m in a Series A financing round to progress the clinical development of AHB-137 for chronic hepatitis ...

Nona Biosciences has partnered with biotechnology company Alaya.bio to work on advancing CAR-T cell therapies.

Australia is fast becoming the place to be for innovative life sciences companies, as proved by Melbourne’s latest FDI wins ...

The US Food and Drug Administration (FDA) has granted fast track designation to Mabwell’s antibody-drug conjugate (ADC).

AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso (osimertinib) to treat NSCLC.

DLX-001 is a neuroplastogen designed to promote neuroplasticity without giving rise to the deleterious attributes of first- ...

Yemen, which is experiencing a civil war, introduced a measles vaccination campaign in May this year. Image Credit: ...

Rinvoq is one of the top revenue-generating therapies for AbbVie, raking in approximately $4bn in sales last year, per the ...

Boehringer Ingelheim’s For Generations framework is all in on sustainability for the long term across the ESG spectrum.

This partnership grants Ipsen worldwide rights to develop, manufacture and commercialise FS001, which is in the final stages ...